K Y Ho1, W H Kalle, T H Lo, W Y Lam, C M Tang. 1. Department of Clinical Pathology, Tuen Mun Hospital, New Territories, Hong Kong. kennyho@hk.super.net
Abstract
AIMS: To investigate if the adenomatous polyposis coli (APC) protein and the deleted in colorectal cancer (DCC) protein expression can be demonstrated by an immuno-histochemical method and to study the role of APC and DCC gene inactivation in the development and progression of breast cancer using colorectal cancer as a control model. METHODS AND RESULTS: The reduced or loss of protein expression of the APC and DCC genes was studied in 27 surgical specimens of primary breast cancer using an immunohistochemical method. Reduced or lost expression was identified in 11 out of 27 samples (40.7%) for the APC gene and 15 out of 27 samples (55.6%) for the DCC gene. No statistically significant difference was observed between the reduced or lost protein expression and the histological grading of breast tumour for both the APC and the DCC gene. CONCLUSIONS: Both gene proteins can be demonstrated by the immunohistochemical method. Reduced or loss of APC and DCC gene product were observed in 40.7% and 55.6% cases of primary breast cancer respectively. Further work is required to investigate the significance of the finding.
AIMS: To investigate if the adenomatous polyposis coli (APC) protein and the deleted in colorectal cancer (DCC) protein expression can be demonstrated by an immuno-histochemical method and to study the role of APC and DCC gene inactivation in the development and progression of breast cancer using colorectal cancer as a control model. METHODS AND RESULTS: The reduced or loss of protein expression of the APC and DCC genes was studied in 27 surgical specimens of primary breast cancer using an immunohistochemical method. Reduced or lost expression was identified in 11 out of 27 samples (40.7%) for the APC gene and 15 out of 27 samples (55.6%) for the DCC gene. No statistically significant difference was observed between the reduced or lost protein expression and the histological grading of breast tumour for both the APC and the DCC gene. CONCLUSIONS: Both gene proteins can be demonstrated by the immunohistochemical method. Reduced or loss of APC and DCC gene product were observed in 40.7% and 55.6% cases of primary breast cancer respectively. Further work is required to investigate the significance of the finding.
Authors: M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries Journal: J Med Genet Date: 2002-04 Impact factor: 6.318
Authors: K Furuuchi; M Tada; H Yamada; A Kataoka; N Furuuchi; J Hamada; M Takahashi; S Todo; T Moriuchi Journal: Am J Pathol Date: 2000-06 Impact factor: 4.307
Authors: Mohamed M Desouki; Shaoxi Liao; Huayi Huang; Jeffrey Conroy; Norma J Nowak; Lori Shepherd; Daniel P Gaile; Joseph Geradts Journal: J Cancer Res Clin Oncol Date: 2010-08-03 Impact factor: 4.553
Authors: JeanMarie Houghton; Hanchen Li; Xueli Fan; Yingwang Liu; Jian Hua Liu; Varada P Rao; Theofilos Poutahidis; Christie L Taylor; Erin A Jackson; Christine Hewes; Stephen Lyle; Anna Cerny; Glennice Bowen; Jan Cerny; Nathan Moore; Evelyn A Kurt-Jones; Susan E Erdman Journal: Stem Cells Dev Date: 2010-08 Impact factor: 3.272
Authors: I Van der Auwera; S J Van Laere; S M Van den Bosch; G G Van den Eynden; B X Trinh; P A van Dam; C G Colpaert; M van Engeland; E A Van Marck; P B Vermeulen; L Y Dirix Journal: Br J Cancer Date: 2008-10-07 Impact factor: 7.640